ÂÜÀòÂÒÂ×

Rick Riley is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as Director of Qualified Treatment Center Engagement at bluebird bio since December 2021. Previously, Rick worked as a Hematology Clinical Account Specialist at Pharmacyclics, an AbbVie Company, from April 2020 to December 2021. Prior to that, Rick spent eight years at Genentech, first as a Senior Clinical Oncology Specialist focusing on lung and bladder tumors, and later as a Senior Clinical Specialist with expertise in rare disease, immunology, and dermatology.